# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-23-031375
Filing Date
2023-09-05
Accepted
2023-09-05 16:02:49
Documents
15
Period of Report
2023-09-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | cccc-20230905.htm iXBRL | 8-K | 36119
2 | EX-99.1 | cccc-20230905xexx991.htm | EX-99.1 | 11442
6 |  | c4tlogoa.jpg | GRAPHIC | 8913
7 |  | kendraadams_hires-5403.jpg | GRAPHIC | 4505417
| Complete submission text file | 0001628280-23-031375.txt |  | 6400968

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cccc-20230905.xsd | EX-101.SCH | 1948
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cccc-20230905_lab.xml | EX-101.LAB | 24851
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cccc-20230905_pre.xml | EX-101.PRE | 13088
9 | EXTRACTED XBRL INSTANCE DOCUMENT | cccc-20230905_htm.xml | XML | 2818

Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 231235664
SIC: 2836 Biological Products, (No Diagnostic Substances)